Maven Clinic raises $ 110 million in Series D funding, ushering in the digital age for women’s and family health
Building on its momentum with global employers and payers, Maven will use its Series D funding to expand to new populations and invest in additional product innovations to further enhance its award-winning member experience designed to enhance clinical results.
Since its foundation in 2014 by the CEO Kate ryder, Maven’s commitment to meeting the unique needs of each member has set a new standard for family care, centered on the principles of access, equity and personalization putting the patient first. Today, Maven is the only platform on the market that combines an extensive specialized telehealth network of over 30 provider types with one-to-one care navigation to support all parents and all paths to parenthood, from parenthood to parenthood. fertility in pregnancy, parenthood and pediatrics. Maven’s compassionate care advocates are at the forefront of helping members navigate the complexities of the family-building journey: from managing high-risk patients to fertility and fertility. motherhood to ensure seamless integration with existing benefits to empowering members to advocate for themselves in a system that has left many parents behind.
“The digital age for women’s and family health has arrived,” said Kate ryder, founder and CEO of Maven. “For far too long this space has been under-researched, undersized and under-innovated, and as a result, it is profoundly underperforming, failing patients during some of the most difficult times of their lives. Supporting our new and existing investors, Maven will be able to deliver on the promise of digital health for women and families around the world, delivering personalized care that meets them where they are. “
“With the largest supplier network, demonstrated success with reputable employers, and a focus on improving clinical outcomes, we believe Maven is the obvious choice for employers and payers,” said Eric Jones, partner at Dragoneer Investment Group, joining Maven’s board of directors. “Maven’s model, which combines technology with clinical providers, is powerful in delivering the right care at the right time and changing the way we think about delivering care. The high usage and engagement of the Maven platform addresses the urgent need that Maven is addressing. I have never seen such exceptional “customer love”, especially in healthcare. We are excited to partner with Kate and her team as they continue to change the face of women’s health and family care. “
“We have been looking for the right company in women’s and family health for a long time because we believe this is one of the defining categories in health. In the process, we rated hundreds of companies and Maven clearly stood out as the category winner. ready to lead the sector, ”said Deena Shakir, partner at Lux Capital, who joins the Board of Directors of Maven. “Individual point solutions fail to meet the greatest unmet need: although the path to parenthood is unique to each family, it is a source of emotional, physical and financial stress for almost all families. Maven is the only platform that effectively serves parenting trips in all their depth and diversity, solving for the patient, employer and payer with one elegant solution. “
The latest funding follows a period of rapid growth for Maven. Since lifting its Series C funding round last year, Maven has significantly increased its customer base among employers and payers, partnering with four new Fortune 15 customers, including Microsoft, with an increase of 400% of Maven employer and payor sponsored program memberships. Even in the midst of this rapid growth, Maven has achieved a retention rate of almost 100% among its existing customers like Boston Scientific, Booz Allen Hamilton, and L’Oréal. Quality and accessibility also remained high, with average wait times of 27 minutes for same-day appointments and an appointment satisfaction score of 4.9 / 5 across all specialties. Maven’s model has been externally validated for better clinical outcomes, including lower NICU admissions and unnecessary Caesarean section rates compared to national averages.
Maven is the largest virtual clinic for women’s and family health, providing ongoing, holistic care for fertility, pregnancy and parenthood. Maven’s award-winning digital programs are endorsed by leading employers and health plans to reduce costs and improve health outcomes for parents and children. Founded in 2014 by the CEO Kate ryder, Maven has been recognized as Fast Company’s Most Innovative Healthcare Company and has supported over 10 million women and families to date. Maven lifted over $ 200 million in the financing of leading investors, notably Sequoia, Oak HC / FT, Dragoneer Investment Group and Lux Capital. To learn more about how Maven is reinventing life’s most critical health moment, visit us at mavenclinic.com.
About the Dragoneer investment group
Dragoneer is a growth-oriented investment firm with more than $ 19 billion in long-term capital of many of the world’s largest endowments, foundations, sovereign wealth funds and family offices. Dragoneer has a history of partnering with leadership teams developing exceptional businesses characterized by sustainable differentiation and superior business models. The history of the company includes public and private investments in all sectors and geographies, with a particular focus on technology-driven companies. Dragoneer has invested in companies such as Airbnb, AmWINS, Ant Financial, ByteDance, Carbon Health, Datadog, DoorDash, Duck Creek, Farfetch, Livongo, Nubank, PointClickCare, ServiceNow, Slack, Snowflake, Spotify, Square, Twilio, Uber, and others.
About Lux Capital
Lux Capital invests in emerging science and technology companies as far as possible. They team up with iconoclastic inventors who challenge the status quo and the laws of nature to bring their futuristic ideas to life. Over the past two decades, Lux has grown from her New York City roots in Silicon Valley and built a $ 4 billion AUM firm of more than 30 full-time professionals, with the versatility to invest at any stage.